Multiomics analysis for dementia

Objectives

Determine biomarkers for Alzheimer's and other neurodegenerative diseases using comprehensive analysis of multi-omics data including genomics, epigenomics, metabolomics, proteomics, etc.

Data

Large cohorts with phenotype data on dementia are available through:

  1. The Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium.
  2. The Trans-Omics for Precision Medicine (TOPMed) program. The TOPMed Omics Survey in 2017 includes Framingham Heart Study (FHS) details, which are described clearer in 2016. SABRe is a substudy of FHS and has mRNA and miRNA data.
  3. Exome Sequencing Project (ESP), richly-phenotyped for heart, lung and blood disorders.
  4. Alzheimer's Disease Sequencing Project (ADSP), WES and WGS of thousands of AD and control samples.
  5. Allen Brain Atlases has many different downloadable data types, but from a few mouse and human samples. RNA-Seq data of hundreds of dementia cases.
  6. The Image and Data Archive (IDA) contains mostly image data on 43,290 subjects from 119 studies.
  7. The Alzheimer's Disease Neuroimaging Initiative (ADNI) has genetic and imaging data of 1-3 K samples, which are available through IDA.
  8. Several studies share their data through Accelerating Medicines Partnership - Alzheimer's Disease (AMP-AD) including:
    1. The Adult Changes in Thought (ACT) measured ~4K proteins in ~50 brains and performed WGCNA. Also, proteome data in BLSA (~100 brains), Banner (~200), and UPPpilot (~200).
    2. CHDWB and HBTRC, each has a gene expression profile from ~500 brains, MC-CAA (75), MCADGS (~100 RNA-Seq and GWAS samples).
    3. The Mount Sinai Brain Bank (MSBB) includes proteome and gene expression profiles from hundreds of samples.
    4. The MayoRNAseq includes WGS and RNA-Seq data from 275 Cerebellum (CBE) and 276 Temporal cortex (TCX) samples.
  9. The Religious Orders Study and Memory and Aging Project (ROSMAP) is the richest dataset in AMP-AD in terms of variety of data types, which include gene expression, genome, proteome, metabolome, and image data. Also, DNA methylation, miRNA, WGS, WES, and even H3K9Ac are available for ~1K samples. The dataset is very well documented, and was used to identify xQTL by Philip De Jager.
  10. Mathys, Hansruedi, et al. “Single-cell transcriptomic analysis of Alzheimer’s disease.” Nature (2019).
    Radek's summary: “Showing ~80K single cell transcriptomic analysis on brain tissues from ~50 patients with Alzheimer's disease. Subpopulations of glia and neurons expressed different gene signatures associated with AD. These enormous cataloging data may help to further pinpoint pathways associated with AD.”, and his plan. Habil's presentation in Biggs journal club on 2 July 2019.

Collaborators

Dr. Sudha Seshadri, the Founding Director of The Glenn Biggs Institute for Alzheimer's & Neurodegenerative Diseases, Dr. Claudia Satizabal, and Dr. Radek Dobrowolski.

Subprojects

Network analysis on proteome data of Fremingham cohort

  1. An interactive timeline of Alzheimer's disease by AlzForum.
  2. Satizabal, Claudia L., et al. “Genetic architecture of subcortical brain structures in over 40,000 individuals worldwide.” bioRxiv (2017): 173831.
    They identified a set of genes that is “significantly enriched for Drosophila orthologs associated with neurodevelopmental phenotypes”.